Contract Pharma

Achieving Operational Excellence in Today’s Fast-Paced Sterile Fill-Finish Market

Anticipating trends, addressing challenges, and providing solutions that enable CDMOs to adapt to market changes.

Jubilant Pharmova arm to invest $300 million in US by FY28 to double sterile injectable capacity

Jubilant HollisterStier invests $300 million to double sterile injectable manufacturing capacity in the US, accelerated by ...
On The Trowel on MSN

How to Fill Heating Pipe Chases Like a Pro | Step-by-Step Guide - Part 5

Learn the proper way to fill heating pipe chases for a clean, professional finish! In this step-by-step guide, I’ll show you ...
GEN - Genetic Engineering and Biotechnology News

Symbiosis Expands Sterile Manufacturing Capacity with Fill/Finish Line Qualification

In July 2025 Symbiosis manufactured its 1,000th sterile batch, marking over 14 years of support for biopharma clients.

Rating Downgrade: Lifecore, Ready To Go, But Problems Remain

Lifecore Biomedical faces stagnant growth despite expanded capacity, cost reductions, and favorable industry trends. Read why ...

Jubilant Pharmova’s sterile injectable manufacturing arm commissions $132 million new line in U.S.

Jubilant HollisterStier LLC launches $132 million sterile fill and finish line, doubling capacity and creating new jobs in ...

Bank of America Securities Maintains a Buy Rating on Vaxcyte (PCVX)

Vaxcyte, Inc. (NASDAQ: PCVX) is one of the best biotech stocks with high potential. In a report released on October 3, Jason ...
The Manila Times

Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in ...

New Agreement with Thermo Fisher Scientific Expands Domestic Capacity to Support Future Commercial Manufacturing of Vaxcyte’s Broad-Spectrum Pneumococcal Conjugate Vaccine Candidates ...
Rheumatology Advisor

FDA Issues CRL for Apitegromab in Spinal Muscular Atrophy

The FDA has issued a Complete Response Letter to Scholar Rock regarding the BLA for apitegromab for the treatment of spinal muscular atrophy.
The Caledonian-Record

Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term ...

New Agreement with Thermo Fisher Scientific Expands Domestic Capacity to Support Future Commercial Manufacturing of Vaxcyte’s Broad-Spectrum Pneumococcal Conjugate Vaccine Candidates ...

Jubilant HollisterStier expands its sterile injectable manufacturing capacity at Spokane unit in the US

Jubilant Pharmova announced today that Jubilant HollisterStier LLC (JHS)a wholly owned subsidiary and a leading North American pharmaceutical contract manufacturer, specialising in sterile injectables ...